Birth control resident survival guide: Difference between revisions
Jump to navigation
Jump to search
Hudakarman (talk | contribs) |
Hudakarman (talk | contribs) |
||
| Line 71: | Line 71: | ||
* Less than 6 wks postpartum | * Less than 6 wks postpartum | ||
* Smoking (age | * Smoking (age ≥ 35, and ≥15 cigarettes per day) | ||
* Hypertension (systolic | * Hypertension (systolic ≥ 160mmHg or diastolic ≥100mmHg) | ||
* Venous thromboembolism (VTE) (current of past history) | * Venous thromboembolism (VTE) (current of past history) | ||
*Thrombophilia (factor V Leiden, APLS) | |||
* Ischemic heart disease | * Ischemic heart disease | ||
* Cerebrovascular accident history | * Cerebrovascular accident history | ||
* Complicated valvular heart disease (pulmonary hypertension, atrial fibrillation, history of subacute bacterial endocarditis) | * Complicated valvular heart disease (pulmonary hypertension, atrial fibrillation, history of subacute bacterial endocarditis) | ||
* Migraine headache with aura or focal neurological symptoms | * Migraine headache with aura or focal neurological symptoms | ||
* Breast cancer ( | * Breast cancer (Active) | ||
* Diabetes with retinopathy/nephropathy/neuropathy | * Diabetes with retinopathy/nephropathy/neuropathy | ||
* Severe cirrhosis | * Severe cirrhosis (avtive or severe liver disease | ||
* Liver tumor (adenoma or hepatoma) | * Liver tumor (adenoma or hepatoma) | ||
* | |||
Relative contraindication | |||
* Mild hypertension (medication-controlled) | |||
* Age ≥ 35 and smoking < 15 cigarettes per day | |||
* Inhirited thrombophilia carrier and family member with thrmbophilia plus thromboembolism | |||
==== IUDs ==== | ==== IUDs ==== | ||
Revision as of 11:17, 13 August 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Birth Control Options
Female birth control options
Long acting reversible contraception(LARC): 99% effective, high rate of satisfaction, long-term use, quick return to fertility when discontinued
- IUDs (> 99% effective)
- Copper IUD: effective for up to 10 years, used for patients with light menstrual periods, desire long-term contraception, not prefer using hormonal contraception
- Progestin-releasing IUD, effective for up to 5 years, for patients with heavy menstrual bleeding and dysmenorrhea
- Subdermal implant (> 99% effective), effective for up to 3 years, SE: unscheduled bleeding, weight gain, headache. Ovulation and fertility occur within one month after removal
- Depot Medroxyprogesterone, IM injection given every 3 months (94% effective),
- Combined hormonal contraceptives
- Oral contraceptive (estrogen/progestin pills) (OCPs) (91% effective)
- Birth Control Patch (91% effective)
- Vaginal Ring (91% effective)
- Barrier Methods
- Diaphragm
- Cervical Cap
- Sponge
- Spermicide (80% failure rate if used alone). Should be used with cervical cap or diaphragm, may damage the genital epithelium and increase risk of acquiring SDIs
- Natural contraception (Natural Family Planning and Fertility Awareness)
- Lactational Amenorrhea Method (LAM) (Breastfeeding can help with child spacing)
- Abstinence
- Permanent Sterilization
Male birth control options
Barrier contraception (Condoms) (80% effective), the only type of contraception that prevent sexual transmitted infections
Vasectomy
Withdrawal (coitus interruptus) (75% effective)
Note:
- You can use IUD in a nulliparous female
- Progestin subdermal implant is more effective that IUD (failure rate .2-.8%) and female fertilization (.5% failure rate)
Emergency contraception
Indications
- Pregnancy prevention
- Treatment of different conditions such as:
- Polycystic Ovary Syndrome (PCOS): OCPs are used for menstrual regulation
- Endometriosis
- Amenorrhea
- Dysmenorrhea
- Premenstrual Syndrome (PMS)
- Primary Ovarian Insufficiency (POI)
- Heavy Menstrual Periods
- Acne
Contraindications
Combined hormonal contraceptives
Absolute contraindications
- Less than 6 wks postpartum
- Smoking (age ≥ 35, and ≥15 cigarettes per day)
- Hypertension (systolic ≥ 160mmHg or diastolic ≥100mmHg)
- Venous thromboembolism (VTE) (current of past history)
- Thrombophilia (factor V Leiden, APLS)
- Ischemic heart disease
- Cerebrovascular accident history
- Complicated valvular heart disease (pulmonary hypertension, atrial fibrillation, history of subacute bacterial endocarditis)
- Migraine headache with aura or focal neurological symptoms
- Breast cancer (Active)
- Diabetes with retinopathy/nephropathy/neuropathy
- Severe cirrhosis (avtive or severe liver disease
- Liver tumor (adenoma or hepatoma)
Relative contraindication
- Mild hypertension (medication-controlled)
- Age ≥ 35 and smoking < 15 cigarettes per day
- Inhirited thrombophilia carrier and family member with thrmbophilia plus thromboembolism
IUDs
- Uterine anomalies
- Active pelvic infection
Relative contraindications
- Smoker over the age of 35 (< 15 cigarettes per day)
- Adequately controlled hypertension
- Hypertension (systolic 140 - 159mmHg or diastolic 90 - 99mmHg)
- Migrain headache over the age of 35
- Currently symptomatic gallbladder disease
- Mild cirrhosis
- History of combined OCP-related cholestasis
Medications that interfere with OCPs:
Subdermal implant
- Progesterone receptor-positive breast cancer
Do's
- Increase the levothyroxine dose in patients with hypothyroidism who started taking OCPs. OCPs (estrogen) increases the liver synthesis of thyroxin-binding globulin (TBG)
- OCPs also decrease the effect of Warfarin, so consider increasing the dose
- Oral contraceptives (estrogen) alter the transport and tissue delivery of thyroid hormone by increasing the synthesis of throxine-binding globulin , relative hypothyroid state in patients with hypothyroidism. Increase the dose of levothyroxine when starting OCPs.